Press release
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In Non-Opioid Pain Treatments For Neuropathy
Diabetic Peripheral Neuropathy
The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The rising global prevalence of obesity is linked to increased awareness, lifestyle changes, and growing demand for preventive and treatment solutions, all of which are contributing to the demand for better DPN management. In March 2024, the World Health Organization (WHO) reported that 43% of adults were overweight, with 16% classified as obese, while childhood obesity is also on the rise. As obesity-related health issues increase, so does the need for treatments addressing complications like diabetic peripheral neuropathy, further fueling the market growth.
Get Your Diabetic Peripheral Neuropathy Market Report Here:
https://www.thebusinessresearchcompany.com/report/diabetic-peripheral-neuropathy-global-market-report
What Is the projected market size and growth rate for the diabetic peripheral neuropathy market?
The diabetic peripheral neuropathy market has experienced strong growth, expanding from $3.51 billion in 2024 to $3.84 billion in 2025 at a CAGR of 9.4%. The market's historical growth has been driven by a rising geriatric population, increasing diabetes prevalence, higher healthcare expenditures, greater awareness of diabetic complications, and improved healthcare infrastructure.
The diabetic peripheral neuropathy market is forecasted to grow significantly, reaching $5.43 billion by 2029 at a CAGR of 9.1%. Growth drivers include an increase in sedentary lifestyles, greater government initiatives and funding, rising prevalence of neuropathy risk factors, improved diagnostic precision, and heightened support for early detection and prevention. Notable trends include advances in diagnostic technologies, technological improvements in treatment options, increased R&D investments, the development of minimally invasive procedures, and a stronger emphasis on collaborative research and development.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21170&type=smp
What new trends are reshaping the diabetic peripheral neuropathy market and its opportunities?
In the diabetic peripheral neuropathy (DPN) market, companies are exploring NaV1.8 pain signal inhibitors for non-opioid pain management. For instance, in April 2024, Vertex Pharmaceuticals Incorporated, a US-based biotech company, advanced its suzetrigine pain program, including a Phase 3 pivotal program for treating DPN pain. Suzetrigine selectively inhibits NaV1.8, a key pain mediator in sensory neurons, showing promising results in earlier studies and receiving FDA breakthrough therapy designation for DPN pain management.
What major market segments define the scope and growth of the diabetic peripheral neuropathy market?
The diabetic peripheral neuropathy market covered in this report is segmented -
1) By Disease: Type 2 Diabetic Peripheral Neuropathy, Type 1 Diabetic Peripheral Neuropathy
2) By Treatment: Pain Management Drugs, Gene Therapies
3) By Therapy: Antidepressants, Anticonvulsants
4) By Patient Population: Adult Patients, Geriatric Patients
Subsegments:
1) By Type 2 Diabetic Peripheral Neuropathy: Sensory Neuropathy, Motor Neuropathy, Autonomic Neuropathy
2) By Type 1 Diabetic Peripheral Neuropathy: Distal Symmetric Neuropathy, Mononeuropathy, Polyradiculopathy
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21170
Which region dominates the diabetic peripheral neuropathy market?
North America was the largest region in the diabetic peripheral neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic peripheral neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the diabetic peripheral neuropathy industry growth?
Major companies operating in the diabetic peripheral neuropathy market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc., Eli Lilly and Company, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Limited, Lupin Pharmaceuticals Inc., Chemie Grünenthal GmbH, Alkem Laboratories Limited, Acorda Therapeutics Inc., Mitsubishi Tanabe Pharma Corporation, NeuroMetrix Inc., Regenacy Pharmaceuticals Inc., Helixmith Co. Ltd., Aptinyx Inc., WinSanTor Inc., Sonnet BioTherapeutics Holdings Inc., OLYS Pharma Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21170&type=smp
What Is Covered In The Diabetic Peripheral Neuropathy Global Market Report?
•Market Size Forecast: Examine the diabetic peripheral neuropathy market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the diabetic peripheral neuropathy market for a structured understanding.
•Key Players Overview: Analyze major players in the diabetic peripheral neuropathy market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the diabetic peripheral neuropathy market.
•Segment Contributions: Evaluate how different segments drive overall growth in the diabetic peripheral neuropathy market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the diabetic peripheral neuropathy market.
•Industry Challenges: Identify potential risks and obstacles affecting the diabetic peripheral neuropathy market.
•Competitive Landscape: Review strategic developments in the diabetic peripheral neuropathy market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In Non-Opioid Pain Treatments For Neuropathy here
News-ID: 3934446 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Neuropathy
Small-Fiber Neuropathy (SFN) Market Poised for Rapid Growth as Demand for Neurop …
The global Small-Fiber Neuropathy (SFN) market is witnessing robust growth, driven by rising diabetic and idiopathic neuropathy prevalence, improved diagnostics, and growing demand for effective therapies. The market is expected to show steady long-term expansion through 2034, signaling strong opportunities for healthcare providers, pharma companies, and investors.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72073
1. Keyword Definition - Small-Fiber Neuropathy (SFN)
Small-Fiber Neuropathy (SFN) is a neurological disorder caused by damage…
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding
WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to…
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market
Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,…
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market?
The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses…
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810
This latest report researches the industry structure,…
Optic Neuropathy Management Market Rising cases of optic neuropathy and advancem …
Global Optic Neuropathy Management Market Overview:
The Optic Neuropathy Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Optic Neuropathy Management market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
